| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ACTB
|
actin, beta
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BID
|
BH3 interacting domain death agonist
|
|
BNIP2
|
BCL2/adenovirus E1B 19kDa interacting protein 2
|
|
CAAP1
|
caspase activity and apoptosis inhibitor 1
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCND1
|
cyclin D1
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD4
|
CD4 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD80
|
CD80 molecule
|
|
CHRAC1
|
chromatin accessibility complex 1
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYCS
|
cytochrome c, somatic
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DFFA
|
DNA fragmentation factor, 45kDa, alpha polypeptide
|
|
DFFB
|
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)
|
|
DMD
|
dystrophin
|
|
EDN1
|
endothelin 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2
|
|
ENDOG
|
endonuclease G
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
|
IFNG
|
interferon, gamma
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL2
|
interleukin 2
|
|
IL6
|
interleukin 6
|
|
ILK
|
integrin-linked kinase
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JAK1
|
Janus kinase 1
|
|
KRT8
|
keratin 8, type II
|
|
LAMA2
|
laminin, alpha 2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MYH6
|
myosin, heavy chain 6, cardiac muscle, alpha
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PTCRA
|
pre T-cell antigen receptor alpha
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
SGCA
|
sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)
|
|
SGCB
|
sarcoglycan, beta (43kDa dystrophin-associated glycoprotein)
|
|
SGCD
|
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein)
|
|
SGCG
|
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TNF
|
tumor necrosis factor
|
